Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.03 mg/3 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo 0.03 mg/3 mg film-coated tablets

laboratorios leon farma, s.a. - ethinylestradiol; drospirenone - film-coated tablet - 0.03/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

Ethinylestradiol/Drospirenon Mylan 0.03 mg - 3 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ethinylestradiol/drospirenon mylan 0.03 mg - 3 mg tabl.

viatris gx bv-srl - ethinylestradiol 0,03 mg; drospirenone 3 mg - tablet - 0,03 mg - 3 mg - ethinylestradiol 0.03 mg; drospirenone 3 mg - drospirenone and ethinylestradiol

Ethinylestradiol/Drospirenon Mylan 0.02 mg - 3 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ethinylestradiol/drospirenon mylan 0.02 mg - 3 mg tabl.

viatris gx bv-srl - ethinylestradiol 0,02 mg; drospirenone 3 mg - tablet - 0,02 mg - 3 mg - ethinylestradiol 0.02 mg; drospirenone 3 mg - drospirenone and ethinylestradiol

YANA drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

yana drospirenone 3 mg and ethinylestradiol 20 microgram film coated tablet blister pack

arrotex pharmaceuticals pty ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; povidone; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - this medicine is indicated for use as: ? an oral contraceptive. ? treatment of moderate acne vulgaris in women who seek oral contraception. ? treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of drospirenone 3 mg /ethinylestradiol 20 ?g for pmdd was not assessed beyond 3 cycles. drospirenone 3 mg /ethinylestradiol 20 ?g has not been evaluated for treatment of pms (premenstrual syndrome), see section 5.1 pharmacodynamic properties - clinical trials.

Ethinylestradiol 10microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ethinylestradiol 10microgram tablets

ucb pharma ltd - ethinylestradiol - oral tablet - 10microgram

Ethinylestradiol 1mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ethinylestradiol 1mg tablets

ucb pharma ltd - ethinylestradiol - oral tablet - 1mg

Ethinylestradiol 50microgram tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ethinylestradiol 50microgram tablets

ucb pharma ltd - ethinylestradiol - oral tablet - 50microgram

Ethinylestradiol/Drospirenone Leon Farma & Placebo 0.02 mg/3 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

ethinylestradiol/drospirenone leon farma & placebo 0.02 mg/3 mg film-coated tablets

laboratorios leon farma, s.a. - drospirenone; ethinylestradiol - film-coated tablet - 0.02/3 milligram(s) - progestogens and estrogens, fixed combinations; drospirenone and ethinylestradiol

GYNERA Israel - English - Ministry of Health

gynera

bayer israel ltd - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - hormonal contraception.

NUVARING Israel - English - Ministry of Health

nuvaring

organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.